Accler8's FY 2011 Revenues Drop 50 Percent | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Accler8's fiscal full-year 2011 revenues dropped by half, the company disclosed after the close of the market on Thursday.

In its annual earnings report filed with the US Securities and Exchange Commission, the Denver-based firm said that revenues for the year ended July 31, 2011, came in at $1.1 million, compared to $2.2 million a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.